Evidence map›Paper›PMID 27084084›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2016

Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome.

Mehmet Tetikoğlu, Haci Murat Sağdik, Serdar Aktas, Fatma Uçar, Fatih Özcura

Abstract readClinical Study
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Evaluation of the optic nerve head vessel density in the patients with asymmetric pseudoexfoliative glaucoma: an OCT angiography study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mehmet TetikoğluDepartment of Ophthalmology, Dumlupinar University School of Medicine, Kutahya, 43270, Turkey. drtetikoglu@yahoo.com.tr.
Haci Murat SağdikDepartment of Ophthalmology, Dumlupinar University School of Medicine, Kutahya, 43270, Turkey.
Serdar AktasDepartment of Ophthalmology, Dumlupinar University School of Medicine, Kutahya, 43270, Turkey.
Fatma UçarDepartment of Biochemistry, Dışkapı Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey.
Fatih ÖzcuraDepartment of Ophthalmology, Dumlupinar University School of Medicine, Kutahya, 43270, Turkey.
Dumlupinar University · TRDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to evaluate the serum prolidase activity (SPA), malondialdehyde (MDA), and catalase levels in patients with pseudoexfoliation (PEX) syndrome.

methodThirty-four patients with PEX syndrome and thirty-eight age- and gender-matched healthy subjects were included in this prospective clinical study. Each participant underwent full ophthalmologic examination. The SPA, serum MDA, and catalase levels were measured and compared between the patients with PEX syndrome and healthy subjects.

resultsThe SPA was significantly lower in patients with PEX syndrome compared to healthy controls (14.1 ± 7.1 vs. 30.1 ± 4.3 ng/ml; p = 0.001). The mean serum MDA values the of PEX syndrome and control groups were comparable (28.7 ± 5.7 vs. 30.4 ± 5.3 nmol/ml, respectively; p = 0.185). The mean serum catalase level tended to be lower in the PEX group compared to healthy controls (0.12 ± 0.02 vs. 0.21 ± 0.05 k/ml, respectively; p = 0.077).

conclusionOur findings suggest that the SPA was significantly lower in patients with PEX syndrome compared to healthy controls. Thus, prolidase may have a role in the pathogenesis of the PEX syndrome.

Indexed as

Oxidative StressAgedBiomarkersCatalaseDipeptidasesEnzyme-Linked Immunosorbent AssayExfoliation SyndromeFemaleFollow-Up StudiesHumansIntraocular PressureMaleMalondialdehydeMiddle AgedProspective StudiesBiomarkersCatalaseDipeptidasesMalondialdehydeproline dipeptidaseCatalaseMalondialdehydePseudoexfoliationSerum prolidase activity

Identifiers

PMID27084084
OpenAlexW2340941674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.